Association between SARS-CoV-2 variants and post COVID-19 condition: findings from a longitudinal cohort study in the Belgian adult population

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Association between SARS-CoV-2 variants and post COVID-19 condition: findings from a longitudinal cohort study in the Belgian adult population ; volume:23 ; number:1 ; day:8 ; month:11 ; year:2023 ; pages:1-11 ; date:12.2023
BMC infectious diseases ; 23, Heft 1 (8.11.2023), 1-11, 12.2023

Creator: Thi Khanh, Huyen Nguyen
Cornelissen, Laura
Castanares-Zapatero, Diego
Pauw, Robby De
Cauteren, Dieter Van
Demarest, Stefaan
Drieskens, Sabine
Devleesschauwer, Brecht
Ridder, Karin De
Charafeddine, Rana
Smith, Pierre

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12879-023-08787-8

URN: urn:nbn:de:101:1-2024012910332929512553

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:37 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Thi Khanh, Huyen Nguyen
Cornelissen, Laura
Castanares-Zapatero, Diego
Pauw, Robby De
Cauteren, Dieter Van
Demarest, Stefaan
Drieskens, Sabine
Devleesschauwer, Brecht
Ridder, Karin De
Charafeddine, Rana
Smith, Pierre
SpringerLink (Online service)

Other Objects (12)

Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV

Peptide variants of a SARS-CoV-2 neutralizing protein

Antibody cocktail effective against variants of SARS-CoV-2

Evolutionary trajectory of SARS-CoV-2 and emerging variants

Functionalized Fullerene for Inhibition of SARS-CoV-2 Variants

Functionalized Fullerene for Inhibition of SARS‐CoV‐2 Variants

Sustained applicability of SARS-CoV-2 variants identification by Sanger Sequencing Strategy on emerging various SARS-CoV-2 Omicron variants in Hiroshima, Japan

Arbeitspapier

Reducing mobility of SARS-CoV-2 variants to safeguard containment

The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants

Scope of SARS-CoV-2 variants, mutations, and vaccine technologies

SARS-CoV-2: phenotype, genotype, and characterization of different variants

Evaluating methodological approaches to assess the severity of infection with SARS-CoV-2 variants: scoping review and applications on Belgian COVID-19 data

Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV

Peptide variants of a SARS-CoV-2 neutralizing protein

Antibody cocktail effective against variants of SARS-CoV-2

Evolutionary trajectory of SARS-CoV-2 and emerging variants

Functionalized Fullerene for Inhibition of SARS-CoV-2 Variants

Functionalized Fullerene for Inhibition of SARS‐CoV‐2 Variants

Sustained applicability of SARS-CoV-2 variants identification by Sanger Sequencing Strategy on emerging various SARS-CoV-2 Omicron variants in Hiroshima, Japan

Arbeitspapier

Reducing mobility of SARS-CoV-2 variants to safeguard containment

The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants

Scope of SARS-CoV-2 variants, mutations, and vaccine technologies

SARS-CoV-2: phenotype, genotype, and characterization of different variants

Evaluating methodological approaches to assess the severity of infection with SARS-CoV-2 variants: scoping review and applications on Belgian COVID-19 data

Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV

Peptide variants of a SARS-CoV-2 neutralizing protein

Antibody cocktail effective against variants of SARS-CoV-2

Evolutionary trajectory of SARS-CoV-2 and emerging variants

Functionalized Fullerene for Inhibition of SARS-CoV-2 Variants

Functionalized Fullerene for Inhibition of SARS‐CoV‐2 Variants

Sustained applicability of SARS-CoV-2 variants identification by Sanger Sequencing Strategy on emerging various SARS-CoV-2 Omicron variants in Hiroshima, Japan

Arbeitspapier

Reducing mobility of SARS-CoV-2 variants to safeguard containment

The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants

Scope of SARS-CoV-2 variants, mutations, and vaccine technologies

SARS-CoV-2: phenotype, genotype, and characterization of different variants

Evaluating methodological approaches to assess the severity of infection with SARS-CoV-2 variants: scoping review and applications on Belgian COVID-19 data

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Association between SARS-CoV-2 variants and post COVID-19 condition: findings from a longitudinal cohort study in the Belgian adult population

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV

Peptide variants of a SARS-CoV-2 neutralizing protein

Antibody cocktail effective against variants of SARS-CoV-2

Evolutionary trajectory of SARS-CoV-2 and emerging variants

Functionalized Fullerene for Inhibition of SARS-CoV-2 Variants

Functionalized Fullerene for Inhibition of SARS‐CoV‐2 Variants

Sustained applicability of SARS-CoV-2 variants identification by Sanger Sequencing Strategy on emerging various SARS-CoV-2 Omicron variants in Hiroshima, Japan

Reducing mobility of SARS-CoV-2 variants to safeguard containment

The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants

Scope of SARS-CoV-2 variants, mutations, and vaccine technologies

SARS-CoV-2: phenotype, genotype, and characterization of different variants

Evaluating methodological approaches to assess the severity of infection with SARS-CoV-2 variants: scoping review and applications on Belgian COVID-19 data

Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV

Peptide variants of a SARS-CoV-2 neutralizing protein

Antibody cocktail effective against variants of SARS-CoV-2

Evolutionary trajectory of SARS-CoV-2 and emerging variants

Functionalized Fullerene for Inhibition of SARS-CoV-2 Variants

Functionalized Fullerene for Inhibition of SARS‐CoV‐2 Variants

Sustained applicability of SARS-CoV-2 variants identification by Sanger Sequencing Strategy on emerging various SARS-CoV-2 Omicron variants in Hiroshima, Japan

Reducing mobility of SARS-CoV-2 variants to safeguard containment

The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants

Scope of SARS-CoV-2 variants, mutations, and vaccine technologies

SARS-CoV-2: phenotype, genotype, and characterization of different variants

Evaluating methodological approaches to assess the severity of infection with SARS-CoV-2 variants: scoping review and applications on Belgian COVID-19 data

Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV

Peptide variants of a SARS-CoV-2 neutralizing protein

Antibody cocktail effective against variants of SARS-CoV-2

Evolutionary trajectory of SARS-CoV-2 and emerging variants

Functionalized Fullerene for Inhibition of SARS-CoV-2 Variants

Functionalized Fullerene for Inhibition of SARS‐CoV‐2 Variants

Sustained applicability of SARS-CoV-2 variants identification by Sanger Sequencing Strategy on emerging various SARS-CoV-2 Omicron variants in Hiroshima, Japan

Reducing mobility of SARS-CoV-2 variants to safeguard containment

The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants

Scope of SARS-CoV-2 variants, mutations, and vaccine technologies

SARS-CoV-2: phenotype, genotype, and characterization of different variants

Evaluating methodological approaches to assess the severity of infection with SARS-CoV-2 variants: scoping review and applications on Belgian COVID-19 data

Related objects

Reset password